Patent · US Active

Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and uses thereof

US9956205B2 · kind B2 · utility

1Cited by

8References

12Claims

0Family size

Assignee

Ardea Biosciences, Inc · US

Inventors

Laszlo R. Treiber · San Diego, US
Irina Zamansky · Oceanside, US
Jean-Luc Girardet · San Diego, US

Key dates

Filing date	May 9, 2016
Grant date	May 1, 2018
Priority date	—
Expiry date	May 9, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D249/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Crystalline polymorph forms of 2-(5-bromo-4-(4-cyclopropyl naphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid are described. Pharmaceutical compositions and the uses of such compounds, compound forms, and compositions for the treatment of a variety of diseases and conditions are also presented.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.